Saudi Pharmaceutical Industries & Medical Appliances Corp - Company Profile
Powered by 
All the sales intelligence you need on Saudi Pharmaceutical Industries & Medical Appliances Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Saudi Pharmaceutical Industries & Medical Appliances Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Saudi Pharmaceutical Industries & Medical Appliances Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) is a vertically integrated generics pharmaceutical manufacturer. The company develops, manufactures, and commercializes pharmaceutical products. It provides products in the form of tablets, capsules, injections, creams, dry powder for suspension, syrups and suspensions, ointments and gels, suppositories, mouthwash, and antiseptic products. SPIMACO has strategic alliances with a global network of pharmaceutical companies and business partners for strategic projects, co-marketing, licensing in and out, co-promotion, contract manufacturing, third-party services, and distribution. The company markets products under the brand names of Handysept, Snafi, Gliptamet, Respira, Quetta, Entapro, Sapofen, Rofenac, Rantudil and Pregadex, among others. The company operates manufacturing facilities in Saudi Arabia, Morocco, Algeria, and Egypt, and its products reach patients in over 18 export markets throughout the MENA region. SPIMACO is headquartered in Riyadh, Saudi Arabia.
Headquarters
Saudi Arabia
Address
P.O.Box 20001, Prince Salman Bin Muhammed Bin Saud Street, Buraydah, Riyadh, Al Qasim, 11455
Website
www.spimaco.com.sa
Telephone
966 1 12523333
No of Employees
1,200
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
2070 (SAU)
Revenue (2024)
$455.3M
1.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
651.4%
(2024 vs 2023)
Market Cap*
$980.4M
Net Profit Margin (2024)
XYZ
639.7%
(2024 vs 2023)
* As of and is in US$
Saudi Pharmaceutical Industries & Medical Appliances Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Tablets | Glatiject |
| Capsules | Floxag |
| Antiseptic Products | Kinzado |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In October, the company entered into an agreement with Boston Oncology Arabia Limited to transfer technology and enable local manufacturing of four specialized oral oncology products. |
| 2025 | Contracts/Agreements | In September, the company signed a credit facility agreement with Saudi National Bank (SNB) at a value of SAR200 million. |
| 2025 | Contracts/Agreements | In March, the company entered into an agreement with CNBG for the supply, manufacturing, and commercialisation of Influenza vaccines in Saudi Arabia and GCC markets. |
Competitor Comparison
| Key Parameters | Saudi Pharmaceutical Industries & Medical Appliances Corp | Astra Industrial Group | Alexandria Co. For Pharmaceuticals & Chemical Industries | Hayat Pharmaceutical Industries | Philadelphia Pharmaceuticals |
|---|---|---|---|---|---|
| Headquarters | Saudi Arabia | Saudi Arabia | Egypt | Jordan | Jordan |
| City | Riyadh | Riyadh | Alexandria | Amman | Amman |
| State/Province | Al Qasim | - | ALEXANDRIA | - | - |
| No. of Employees | 1,200 | - | 1,776 | 191 | 162 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mohammed Alassmari | Chief Human Resources Officer | Senior Management | - | - |
| Khalid Abdulrahman Alqwaiz | Chairman | Executive Board | - | - |
| Ahmed bin Hamdan Al-Jedai | Managing Director; Deputy Chairman | Executive Board | - | - |
| Ahmad Hamdan Aljedai | Deputy Chairman; Managing Director | Executive Board | - | - |
| Jerome Christian Roger Cabannes | Chief Executive Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer